Who owns ADIAL PHARMACEUTICALS INC?
- Ticker: ADIL
- CUSIP Number: 00688a205
Tip: Access positions for across all investors
Analyze quarterly positions in Adial Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Adial Pharmaceuticals stock
Who bought or sold ADIAL PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Manchester Capital Management | 48k | $48k | 0% | Sep 2024 |
|
Geode Capital Management | 46k | $45k | 76% | Sep 2024 |
|
Citadel Advisors | 33k | $33k | 34% | Sep 2024 |
|
BlackRock | 28k | $28k | 100% | Sep 2024 |
|
BlackRock | 28k | $32k | 264% | Jun 2024 |
|
Tower Research Capital | 5.6k | $6.5k | 22% | Jun 2024 |
|
1620 Investment Advisors | 3.6k | $3.6k | 0% | Sep 2024 |
|
Bank of America Corporation | 52.00 | $52.000000 | -92% | Sep 2024 |
|
Benjamin F. Edwards & Company | 40.00 | $0 | 0% | Jun 2024 |
|
Morgan Stanley | 39.00 | $44.998200 | 160% | Jun 2024 |
|
Abound Wealth Management | 27.00 | $27.000000 | 0% | Sep 2024 |
|
Qube Research & Technologies | 8.00 | $10.000000 | 0% | Jun 2024 |
|
Who sold out of Adial Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Renaissance Technologies | Jun 2024 | 34k | $40k |
Hrt Financial | Jun 2024 | 29k | $33k |
Advisor Group Holdings | Mar 2024 | 2.5k | $3.3k |
Royal Bank of Canada | Jun 2024 | 19.00 | $0 |